EcoDrugPlus

Solute Carrier Family 9 Member A3

Ensembl ID : ENSONIG00000013755
Gene Symbol: SLC9A3
4 Cross references
223 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSONIG00000019645
Gene Symbol: SSTR2
4 Cross references
192 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSONIG00000021384
Gene Symbol: SSTR2
4 Cross references
192 Possible Orthologues:

Somatostatin Receptor 3

Ensembl ID : ENSONIG00000013851
Gene Symbol: SSTR3
2 Cross references
183 Possible Orthologues:

Somatostatin Receptor 5

Ensembl ID : ENSONIG00000021451
Gene Symbol: SSTR5
3 Cross references
188 Possible Orthologues:

Sphingosine Kinase 2

Ensembl ID : ENSONIG00000006545
Gene Symbol: SPHK2
2 Cross references
200 Possible Orthologues:

Sphingosine-1-Phosphate Receptor 1

Ensembl ID : ENSONIG00000020775
Gene Symbol: S1PR1
3 Cross references
200 Possible Orthologues:

Spleen Associated Tyrosine Kinase

Ensembl ID : ENSONIG00000011225
Gene Symbol: SYK
4 Cross references
200 Possible Orthologues:

Steroid 17-Alpha-Hydroxylase/17,20 Lyase-Like

Ensembl ID : ENSONIG00000009168
Gene Symbol: CYP17
2 Cross references
210 Possible Orthologues:

Steroid 5 Alpha-Reductase 2

Ensembl ID : ENSONIG00000027842
Gene Symbol: SRD5A2
3 Cross references
191 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSONIG00000001963
Gene Symbol: SOAT1
4 Cross references
210 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSONIG00000016011
Gene Symbol: TACR1
4 Cross references
195 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).